Reuters - U.S. vaccine advisers recommended
adding two multiple vaccines to the regular childhood schedule
on Thursday — Sanofi Aventis’s Pentacel, which protects
against five infections at once, and GlaxoSmithKline Plc’s
Kinrix, which protects against four of them.










